The advent of smartphone technology and mobile applications has increased the potential impact and scope of mobile health drastically, but the challenges of bringing this technology into wider practice are substantial. Health care professionals should proactively address the challenges associated with bringing mobile health solutions into practice to maximize their benefits.

A previous analysis from the US Food and Drug Administration (FDA) regulatory studies showed that very few mobile health software technologies receive approval for clinical studies. Therefore, we present our new cardiovascular detection and hypertension analysis software. This FDA approved technology makes collecting cardio data easy and finds the best perception and caters to the needs of the public.